WW
WWH.LSE Worldwide Healthcare Trust Plc
- Market cap
- GBX 1.31B
- P/E
- 15.6x
- P/B
- 0.96x
- ROE
- 8.2%
- Dividend yield
- 0.61%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2026.
Is WWH.LSE undervalued?
Graham numberWWH.LSE trades 18.5% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Worldwide Healthcare Trust Plc fundamental analysis
No fundamental analysis for Worldwide Healthcare Trust Plc yet.
Worldwide Healthcare Trust Plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Worldwide Healthcare Trust Plc
Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap companies with a market capitalization of at least $5 billion. The fund employs …
Full company profileWorldwide Healthcare Trust Plc financial statements
Worldwide Healthcare Trust Plc annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 252M | 32.2M | 172M | 96.3M | 484M | -132M | -2.23M | 235M | -198M | 12.5M |
| Gross Profit | 252M | 32.2M | 178M | 115M | 537M | -133M | 34.3M | 208M | -205M | -47.0K |
| Operating Income | 250M | 30.3M | 172M | 102M | 486M | -131M | 15.6M | 204M | -209M | 119M |
| EBITDA | 250M | 30.3M | 172M | 102M | 486M | -131M | 15.5M | 204M | -209M | 117M |
| Net Income | 248M | 27.2M | 166M | 90.8M | 477M | -142M | -8.79M | 201M | -210M | 113M |
| EPS | 5.32 | 0.57 | 0.33 | 0.17 | 0.80 | -0.22 | -0.01 | 0.34 | -0.40 | 0.27 |
| Balance Sheet | ||||||||||
| Total Assets | 1.21B | 1.21B | 1.45B | 1.70B | 2.48B | 2.42B | 2.25B | 2.19B | 1.78B | 1.43B |
| Total Liabilities | 109M | 109M | 21.7M | 165M | 101M | 153M | 99.2M | 113M | 97.4M | 45.6M |
| Shareholders' Equity | 1.10B | 1.10B | 1.43B | 1.54B | 2.38B | 2.27B | 2.15B | 2.08B | 1.68B | 1.39B |
| Cash & Short-term Investments | 10.8M | 9.93M | 49.0M | 3.81M | 29.6M | 26.6M | 58.9M | 73.8M | 93.6M | 70.8M |
| Total Debt | 98.3M | 98.3M | - | 154M | 49.9M | 114M | 55.9M | 68.9M | 68.1M | 18.9M |
| Cash Flow | ||||||||||
| Operating Cash Flow | - | 2.12M | 2.12M | 2.12M | 931K | -13.3M | 5.39M | 2.26M | -1.54M | -3.30M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.30M |
| Free Cash Flow | - | - | - | 2.12M | 931K | -13.3M | 5.39M | 2.26M | -1.54M | -775K |
| Ratios | ||||||||||
| ROE | 22.6% | 2.5% | 11.6% | 5.9% | 20.0% | -6.2% | -0.4% | 9.7% | -12.5% | 8.2% |
| ROA | 20.5% | 2.2% | 11.4% | 5.3% | 19.2% | -5.8% | -0.4% | 9.2% | -11.8% | 7.9% |
| Net Profit Margin | 98.6% | 84.4% | 96.6% | 94.3% | 98.5% | - | - | 85.5% | - | 904.5% |
| Debt to Equity | 0.09x | 0.09x | - | 0.10x | 0.02x | 0.05x | 0.03x | 0.03x | 0.04x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Worldwide Healthcare Trust Plc dividends
- Dividend yield
- 0.61%
- Forward dividend
- 0.02 GBX
- Payout ratio
- 9.6%
- Ex-dividend date
- Jun 11, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | GBP 10.9M | 0.03 | 9.6% |
| 2025 | GBP 14.8M | 0.03 | - |
| 2024 | GBP 18.7M | 0.03 | 9.3% |
| 2023 | GBP 17.2M | 0.03 | - |
| 2022 | GBP 14.7M | 0.02 | - |
| 2021 | GBP 14.5M | 0.02 | 3.0% |
| 2020 | GBP 14.0M | 0.03 | 15.5% |
| 2019 | GBP 14.0M | 0.03 | 8.4% |
| 2018 | GBP 14.0M | 0.29 | 51.6% |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 10:1 on Jul 27, 2023.
Who owns Worldwide Healthcare Trust Plc
- Insiders 0.50%
- Institutions 35.89%
- Public & others 63.61%
- Shares outstanding 337M
- Free float 173M
Worldwide Healthcare Trust Plc company profile
- Company name
- Worldwide Healthcare Trust Plc
- Ticker
- WWH.LSE
- ISIN
- GB0003385308
- Exchange
- London Exchange
- Sector
- Financial Services
- Industry
- Capital Markets
- Fiscal year end
- March
- Address
- 601 Lexington Avenue, New York, NY, United States, 10022
- Phone
- 212 739 6400
- Website
- worldwidewh.com
About Worldwide Healthcare Trust Plc
Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap companies with a market capitalization of at least $5 billion. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Healthcare Index. The fund employs internal research to make its investments. It was formerly known as Finsbury Worldwide Pharmaceutical Trust plc. Worldwide Healthcare Trust PLC was formed in April 1995 and is domiciled in the United Kingdom.
Worldwide Healthcare Trust Plc management
1- Mr. Samuel David IsalyFounder and Director · born 1945